Study of the streptavidin- biotin model system is providing molecular insight into the structure-function relationships, which govern the high affinity equilibrium thermodynamics and the construction of the high activation barrier to dissociation. A mechanistic model of the dissociation reaction coordinate is also emerging and further studies will test the validity of the transition state structural model by both experimental and computational techniques. Because streptavidin utilizes common aromatic, hydrogen bonding, and flexible loop interaction motifs to generate uncommonly high- affinity, the principles elucidated here should prove generally useful to the field of structure-based drug design. In order to connect fundamental advances to drug design, the investigators have added a computational component. State-of-the-art computational approaches will help interpret the thermodynamic findings, investigate the ligand exit pathway, and connect our findings to structure based drug design algorithms. Two new questions concerning the roles of particular protein residues in ligand binding are the focus of this project. First, are some side-chain contacts designed to manage the enthalpic or entropic components of binding free energy depending on the specific physical properties of the portion of the ligand they interact with? For example, do residues contacting portions of a ligand expected to have high configurational entropy (such as the valeric acid tails of biotin) have a different energetic challenge than those residues contacting portions of the ligand which are relatively rigid (such as the bicyclic ring portion of biotin)? The second question is whether particular amino acids manage activation barrier energetics rather than primarily serving as equilibrium contacts? In enzymes, some side-chains are designed to preferentially manage the activation barrier. Is that true for some protein-ligand contacts as well? This project will fill important gaps in the fundamental understanding of 1) what is called mechanistic thermodynamics - which describes how aromatic, hydrogen bonding, and flexible loop side-chain contacts manage the enthalpic and entropic costs of ligand immobilization, 2) the construction of ligand dissociation activation barriers and how binding contacts manage activation enthalpies and entropies, and 3) ligand dissociation mechanisms and whether there are defined ligand exit pathways. This project could also provide useful input for the design of enzymes (e.g., catalytic antibodies), where the problem of product inhibition is essentially a problem of the dissociation activation barrier. The streptavidin mutants could also be useful reagents in affinity separations, diagnostics, and targeted drug discovery.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK049655-05
Application #
6177196
Study Section
Biophysical Chemistry Study Section (BBCB)
Program Officer
Laughlin, Maren R
Project Start
1995-06-01
Project End
2003-03-31
Budget Start
2000-04-01
Budget End
2001-03-31
Support Year
5
Fiscal Year
2000
Total Cost
$194,684
Indirect Cost
Name
University of Washington
Department
Biomedical Engineering
Type
Schools of Engineering
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Rinne, Johanna; Albarran, Brian; Jylhava, Juulia et al. (2007) Internalization of novel non-viral vector TAT-streptavidin into human cells. BMC Biotechnol 7:1
Le Trong, Isolde; Humbert, Nicolas; Ward, Thomas R et al. (2006) Crystallographic analysis of a full-length streptavidin with its C-terminal polypeptide bound in the biotin binding site. J Mol Biol 356:738-45
Albarran, Brian; To, Richard; Stayton, Patrick S (2005) A TAT-streptavidin fusion protein directs uptake of biotinylated cargo into mammalian cells. Protein Eng Des Sel 18:147-52
Hamblett, Kevin J; Press, Oliver W; Meyer, Damon L et al. (2005) Role of biotin-binding affinity in streptavidin-based pretargeted radioimmunotherapy of lymphoma. Bioconjug Chem 16:131-8
Le Trong, Isolde; Freitag, Stefanie; Klumb, Lisa A et al. (2003) Structural studies of hydrogen bonds in the high-affinity streptavidin-biotin complex: mutations of amino acids interacting with the ureido oxygen of biotin. Acta Crystallogr D Biol Crystallogr 59:1567-73
Le Trong, Isolde; McDevitt, Todd C; Nelson, Kjell E et al. (2003) Structural characterization and comparison of RGD cell-adhesion recognition sites engineered into streptavidin. Acta Crystallogr D Biol Crystallogr 59:828-34
Hamblett, Kevin J; Kegley, Brian B; Hamlin, Don K et al. (2002) A streptavidin-biotin binding system that minimizes blocking by endogenous biotin. Bioconjug Chem 13:588-98
Dixon, Richard W; Radmer, Randall J; Kuhn, Bernd et al. (2002) Theoretical and experimental studies of biotin analogues that bind almost as tightly to streptavidin as biotin. J Org Chem 67:1827-37
Stayton, P S; Hoffman, A S; Murthy, N et al. (2000) Molecular engineering of proteins and polymers for targeting and intracellular delivery of therapeutics. J Control Release 65:203-20
Hyre, D E; Le Trong, I; Freitag, S et al. (2000) Ser45 plays an important role in managing both the equilibrium and transition state energetics of the streptavidin-biotin system. Protein Sci 9:878-85

Showing the most recent 10 out of 20 publications